Seaport Therapeutics, Inc. (SPTX)

Seaport Therapeutics, Inc. (SPTX) is a healthcare company (biotechnology) based in the United States. The share price is $18.29, down 4.34% on the day, which values the company at $979.07M. Price as of 17 Nov 2026, 17:28 UTC, from Yahoo Finance.

Key facts

Share price
$18.29−4.34% today
Market value
$979.07M
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Seaport Therapeutics, Inc. in more detail

SPTX trades at -7.6× next year's expected earnings.

In its favour: More cash than debt. Worth checking: Weak Piotroski score.

1 of the superinvestors tracked here hold SPTX, including Peter Kolchinsky (0.1% of the portfolio).

Superinvestors holding SPTX

1 of the investors tracked here report a position in their latest 13F filing.

Seaport Therapeutics, Inc. (SPTX): questions and answers

What is Seaport Therapeutics, Inc.'s market cap?

Seaport Therapeutics, Inc. is valued at $979.07M at a share price of $18.29.

Does SPTX pay a dividend?

Seaport Therapeutics, Inc. does not currently pay a regular dividend.

Which famous investors own SPTX?

In their latest quarterly filings, Peter Kolchinsky (0.1% of the portfolio) hold SPTX. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Seaport Therapeutics, Inc. (SPTX) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/SPTX

Underlying data: Yahoo Finance; company filings with the SEC.